Therapeutic step-up strategy for management of hereditary pancreatitis in children

S Kargl1, M Kienbauer2, H C Duba3

  • 1Department of Pediatric Surgery, Women's and Children's Hospital Linz.

Insights

A step-up treatment plan using early endoscopic retrograde cholangiopancreatography (ERCP) and surgery effectively manages hereditary pancreatitis in children, preventing recurrence and ensuring a normal quality of life.

Area of Science:

  • Pediatric Gastroenterology
  • Hereditary Pancreatitis Treatment
  • Minimally Invasive Surgery

Background:

  • Hereditary pancreatitis in childhood presents diverse treatment challenges.
  • Current therapeutic options require a structured approach.

Purpose of the Study:

  • To propose and evaluate a therapeutic pathway for childhood hereditary pancreatitis.
  • Emphasis on integrating endoscopic and surgical interventions.

Main Methods:

  • Prospective inclusion of 12 pediatric patients with hereditary pancreatitis (2006-2013).
  • Implementation of a therapeutic step-up schema involving diagnostic work-up and interventions.
  • Evaluation of treatment outcomes correlated with etiological factors and pathoanatomic findings.

Main Results:

  • Early endoscopic retrograde cholangiopancreatography (ERCP) was successful in 10 of 12 patients.
  • Eight patients with obstructive pancreatitis required sphincterotomy, dilation, and stenting.
  • Open surgical drainage was performed for two patients with unsuccessful ERCP.
  • After a mean 32-month follow-up, all patients were free of pancreatitis recurrence.

Conclusions:

  • A step-plan approach with early ERCP is effective for hereditary pancreatitis in children.
  • Open surgical drainage is a viable option for cases with impossible or insufficient endoscopic treatment.
  • This strategy prevents recurrent pancreatitis and ensures a normal quality of life with minimal complications.
Abstract

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
532
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
1.1K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
928
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
690
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
360